SL
Silence Therapeutics
SLN·NASDAQLondon UKFounded 1994150 employees
Small CapbiotechPublicCardiologyHematology
Platform: mRNAi GalNAc
Market Cap
$0.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (SLN)
Loading SLN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SLN-6859 | SLN-6859 | Phase 2 | 2 | GPRC5D | CTCLFTD | ||
| SLN-2895 | SLN-2895 | Preclinical | 2 | CD20 | Pancreatic CaCSU |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)